Medical Treatment of Advanced Hepatocellular Carcinoma Patients: The Issue Is Not the Right Drug, but the Right Patient

Hepatology. 2019 Jul;70(1):429-430. doi: 10.1002/hep.30521. Epub 2019 Mar 13.

Authors

Camillo Porta^{1

2}, Chiara Broglia³, Francesca Negri⁴

Affiliations

¹ Department of Internal Medicine, University of Pavia, Pavia, Italy.
² Division of Translational Oncology, I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy.
³ Unit of Palliative Care, Division of Medical Oncology, I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.
⁴ Division of Medical Oncology, Azienda Ospedaliero-Universitaria, Parma, Italy.

PMID: 30681728
DOI: 10.1002/hep.30521

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents / therapeutic use*
Carcinoma, Hepatocellular / drug therapy*
Humans
Liver Neoplasms / drug therapy*
Sorafenib / therapeutic use*

Substances

Antineoplastic Agents
Sorafenib